HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage.

Abstract
This study focuses on the alterations suffered by the serotoninergic and kinurenergic routes of tryptophan (TRP) metabolism in liver, and their relation with gluconeogenic phosphoenolpyruvate-carboxykinase (PEPCK) blockage in experimental acute porphyria. This porphyria was induced in rats by a combined treatment of 2-allyl-2-isopropylacetamide (100, 250, 500 mg/kg bw) and 3,5-dietoxicarbonil 1,4-dihydrocollidine (constant 50 mg/kg bw dose). Results showed a marked dose-dependent increase of all TRP pyrrolase (TRPp) forms, active (holo, total) and inactive (apo), and a decrease in the degree of enzyme saturation by heme. Increases for holo, total, and apo-TRPp were 90, 150, and 230%, respectively, at the highest dose assayed (H). The treatment also impaired the serotoninergic route of TRP metabolism in liver, causing a decrease in serotonin level (H, 38%), and a concomitant enhancement in TRP content (H, 23%). The porphyrinogenic treatment promoted a blockage in PEPCK activity (H, 30%). This occurred in correlation to the development of porphyria, to TRPp alterations and to the production of hepatic microsomal thiobarbituric acid reactive substances. Porphyria was estimated through increases in 5-aminolevulinic acid-synthase (ALA-S) activity, ALA and porphobilinogen contents, and a decrease in ferrochelatase activity. Thus, the TRP kynurenine route was augmented whereas the serotoninergic route was reduced. PEPCK blockage could be partly attributed to quinolinate generated from TRP by the increase of TRPp activity, which would be due to the effect of porphyrinogenic drugs on TRP. The contribution of ROS to PEPCK blockage is analyzed. Likewise, the implication of these results in the control of porphyrias by glucose is discussed.
AuthorsSandra M Lelli, Marta B Mazzetti, Leonor C San Martín de Viale
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 75 Issue 3 Pg. 704-12 (Feb 01 2008) ISSN: 0006-2952 [Print] England
PMID17996218 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allylisopropylacetamide
  • Dicarbethoxydihydrocollidine
  • Tryptophan
  • 5-Aminolevulinate Synthetase
  • Phosphoenolpyruvate Carboxykinase (ATP)
Topics
  • 5-Aminolevulinate Synthetase (metabolism)
  • Acute Disease
  • Allylisopropylacetamide (toxicity)
  • Animals
  • Dicarbethoxydihydrocollidine (toxicity)
  • Dose-Response Relationship, Drug
  • Female
  • Gluconeogenesis
  • Liver (metabolism)
  • Phosphoenolpyruvate Carboxykinase (ATP) (antagonists & inhibitors)
  • Porphyrias (chemically induced, metabolism)
  • Rats
  • Rats, Wistar
  • Tryptophan (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: